Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Nucleic acid molecules for reduction of PAPD5 or PAPD7 mRNA for treating hepatitis B infection

Nucleic acid molecules for reduction of PAPD5 or PAPD7 mRNA for treating hepatitis B infection

US Patent 11534452 · Granted Dec 27, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Oligonucleotides for modulating RTEL1 expression2025
Nucleic acid molecule for reduction of PAPD5 and PAPD7 mRNA for treating hepatit2025
Nucleic acid molecule for reduction of PAPD5 and PAPD7 mRNA for treating hepatit2025
Oligomers and oligomer conjugates2025
Oligomers and oligomer conjugates2025
Oligonucleotides for inducing paternal UBE3A expression2025
Oligonucleotides for modulating SCN9A expression2024
Interleukin-2 variant proteins fused to human IgG4 Fc and uses thereof2024
Enhanced oligonucleotides for inhibiting RTEL1 expression2024
Enhanced oligonucleotides for inhibiting RTEL1 expression2024
Oligonucleotides for inducing paternal UBE3A expression2023
Use of FUBP1 inhibitors for treating hepatitis B virus infection2023